AI tool could make fibroid treatment more precise
NCT ID NCT07230444
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new AI-powered software that helps doctors see, in real time, how well a minimally invasive fibroid treatment (uterine artery embolization) is working. The goal is to make the procedure more accurate and consistent. The study will involve 250 women with symptomatic uterine fibroids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UTERINE FIBROIDS (UF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
IRCCS OSpedale Policlinico San Martino
Genova, Genova, 16100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a One-Two punch shrink fibroids better?
- Could a tiny electrical zap ease pelvic pain after fibroid procedure?
- Sound waves vs. scalpel: new trial tests ultrasound as fibroid fix
- Nerve block eases Post-Surgery insomnia and anxiety in women
- Hair loss side effect under scrutiny in fibroid drug study
- Battle of the scarless surgeries: which hysterectomy technique wins?